DRSC/TRiP Functional Genomics Resources

powered by:
logo

back to: DIOPT - Ortholog Prediction Tool / DIOPT for Diseases and Traits


Protein Alignment ANKRD44 and ankrd28

DIOPT Version :10

Sequence 1:NP_001354424.1 Gene:ANKRD44 / 91526 HGNCID:25259 Length:1074 Species:Homo sapiens
Sequence 2:XP_031760399.1 Gene:ankrd28 / 734050 XenbaseID:XB-GENE-5857499 Length:1113 Species:Xenopus tropicalis


Alignment Length:1126 Identity:735/1126 - (65%)
Similarity:853/1126 - (75%) Gaps:110/1126 - (9%)


- Green bases have known domain annotations that are detailed below.


Human    10 PPLVQAIFSGDPEEIRMLIHKTEDVNTLDSEKRTPLHVAAFLGDAEIIELLILSGARVNAKDNMW 74
            ||||||||:|||:|:|.||.|.||||..|:|||||||.||:|||||||||||||||||||||:.|
 Frog    37 PPLVQAIFNGDPDEVRALIFKKEDVNFQDNEKRTPLHAAAYLGDAEIIELLILSGARVNAKDSKW 101

Human    75 LTPLHRAVASRSEEAVQVLIKHSADVNARDKNWQTPLHVAAANKAVKCAEVIIPLLSSVNVSDRG 139
            ||||||||||.||:|||||:||||||||||||||||||:|||||||||||.::||||:||||||.
 Frog   102 LTPLHRAVASCSEDAVQVLLKHSADVNARDKNWQTPLHIAAANKAVKCAEALVPLLSNVNVSDRA 166

Human   140 GRTALHHAALNGHVEMVNLLLAKGANINAFDKKDRRALHWAAYMGHLDVVALLINHGAEVTCKDK 204
            |||||||||.:||||||:|||::||||||||||||||:||||||||::||.||:.|||||.||||
 Frog   167 GRTALHHAAFSGHVEMVSLLLSRGANINAFDKKDRRAIHWAAYMGHIEVVKLLVTHGAEVMCKDK 231

Human   205 KGYTPLHAAASNGQINVVKHLLNLGVEIDEINVYGNTALHIACYNGQDAVVNELIDYGANVNQPN 269
            |.|||||||||:|.|:|:|:||:|||:::|.|.||||.||:|||||||.|||||||.||||||.|
 Frog   232 KSYTPLHAAASSGMISVIKYLLDLGVDMNESNAYGNTPLHVACYNGQDVVVNELIDCGANVNQVN 296

Human   270 NNGFTPLHFAAASTHGALCLELLVNNGADVNIQSKDGKSPLHMTAVHGRFTRSQTLIQNGGEIDC 334
            ..||||||||||||||||||||||.|||||||:|||||:||||||:||||:|||.:||||.||||
 Frog   297 ERGFTPLHFAAASTHGALCLELLVCNGADVNIKSKDGKTPLHMTAIHGRFSRSQIIIQNGAEIDC 361

Human   335 VDKDGNTPLHVAARYGHELLINTLITSGADTAKCGIHSMFPLHLAALNAHSDCCRKLLSSGQKYS 399
            .||:||||||:||||||||||||||||.|||:|.|||.|||||||||:..||||||||||     
 Frog   362 EDKNGNTPLHIAARYGHELLINTLITSRADTSKRGIHGMFPLHLAALSGFSDCCRKLLSS----- 421

Human   400 IVSLFSNEHVLSAGFEIDTPDKFGRTCLHAAAAGGNVECIKLLQSSGADFHKKDKCGRTPLHYAA 464
                         ||:|||.|.||||||||||||||:||:.||.|:||||:||||.|||||||||
 Frog   422 -------------GFDIDTHDDFGRTCLHAAAAGGNLECLNLLLSTGADFNKKDKFGRTPLHYAA 473

Human   465 ANCHFHCIETLVTTGANVNETDDWGRTALHYAAASDMDRNKTILGNAHDNSEELERARELKEKEA 529
            |||::.|:..||.:||:||:.|:.|.:.|||||.||.|..                         
 Frog   474 ANCNYQCLFALVGSGASVNDLDERGCSPLHYAATSDTDGK------------------------- 513

Human   530 TLCLEFLLQNDANPSIRDKEGYNSIHYAAAYGHRQCLELLLERT-------NSG---FEESDSGA 584
              |||:||:|||||.||||.|||::|||||||||.||||:...|       .||   ..::::.|
 Frog   514 --CLEYLLRNDANPGIRDKHGYNAVHYAAAYGHRLCLELIARETPLDVLMETSGTDMLNDAETRA 576

Human   585 TKSPLHLAAYNGHHQALEVLLQSLVDLDIRDEKGRTALDLAAFKGHTECVEALINQGASIFVKDN 649
            ..||||||||:|||||||||:|||:|||:|:..|||.|||||||||.|||:.||||||||.|||.
 Frog   577 PISPLHLAAYHGHHQALEVLVQSLLDLDVRNSTGRTPLDLAAFKGHVECVDVLINQGASILVKDY 641

Human   650 VTKRTPLHA---------------------------------SVINGHTLCLRLLLEIADNPEAV 681
            |.||||:|:                                 |.||||:.|||||:..||...||
 Frog   642 VVKRTPIHSAEIQMVDSRNSVNKNNTELCNSAQKKVRAKDMPSAINGHSECLRLLIGNADVQAAV 706

Human   682 DVKDAKGQTPLMLAVAYGHIDAVSLLLEKEANVDTVDILGCTALHRGIMTGHEECVQMLLEQEVS 746
            |:.|..|||||||:|..||.:.|..||.|.||||..|..|.||||||.:|||||||:.||:...:
 Frog   707 DIHDGNGQTPLMLSVLNGHTECVYSLLNKGANVDAKDKWGRTALHRGAVTGHEECVEALLQHNAN 771

Human   747 ILCKDSRGRTPLHYAAARGHATWLSELLQMALSEEDC-CFKDNQGYTPLHWACYNGNENCIEVLL 810
            .|.:|.|||||:|.|||.||...||.|||.|:|.:.. ...||.||||||||||||::.|:|:||
 Frog   772 FLLRDCRGRTPIHLAAACGHIGVLSALLQTAISVDVVPAIADNHGYTPLHWACYNGHDACVELLL 836

Human   811 EQKCFRKFIGNPFTPLHCAIINDHGNCASLLLGAIDSSIVSCRDDKGRTPLHAAAFADHVECLQL 875
            ||:.|:|..||.|:|||||:|||:...|.:|:..:.:|||:..|.|||||||||||.||:|||||
 Frog   837 EQEVFQKMEGNSFSPLHCAVINDNEGAAEMLIDTLGTSIVNSVDSKGRTPLHAAAFTDHIECLQL 901

Human   876 LLRHSAPVNAVDNSGKTALMMAAENGQAGAVDILVNSAQADLTVKDKDLNTPLHLACSKGHEKCA 940
            ||.|:|.|||||::|||.|||||||||..||::||:||:||||::||:.||.||||||||||..|
 Frog   902 LLSHNAQVNAVDSTGKTPLMMAAENGQTSAVEVLVSSAKADLTLQDKNKNTALHLACSKGHETSA 966

Human   941 LLILDKIQDESLINEKNNALQTPLHVAARNGLKVVVEELLAKGACVLAVDENGHTPALACAPNKD 1005
            ||||::|.|.:|||..|:||||||||||||||.|||:|||.|||.||||||||:|||||||||||
 Frog   967 LLILEQITDRNLINATNSALQTPLHVAARNGLTVVVQELLGKGASVLAVDENGYTPALACAPNKD 1031

Human  1006 VADCLALILATMMPFS-----PSSTMMAVNFVCLKKDNLSRT-TLSNLGSM----VSLCS-NNVG 1059
            ||||||||||||||.|     ||.|:.|:|..    :|.|:| |...|..|    .|.|| ||:|
 Frog  1032 VADCLALILATMMPVSSSSSLPSMTLNAINHY----NNTSKTVTFDTLPVMRSEHSSYCSFNNIG 1092

Human  1060 SEDGY------NENDSDSETF 1074
            .||||      ..|||||||:
 Frog  1093 REDGYPYTEEDELNDSDSETY 1113

Known Domains:


Indicated by green bases in alignment.

GeneSequenceDomainRegion External IDIdentity
ANKRD44NP_001354424.1 ANK 1 7..36 19/25 (76%)
Ank_4 10..61 CDD:372654 39/50 (78%)
ANK repeat 11..38 CDD:293786 19/26 (73%)
ANK repeat 40..71 CDD:293786 28/30 (93%)
ANK 2 40..69 26/28 (93%)
ANKYR 54..343 CDD:440430 236/288 (82%)
ANK 3 73..102 24/28 (86%)
ANK repeat 76..104 CDD:293786 24/27 (89%)
ANK repeat 106..137 CDD:293786 25/30 (83%)
ANK 4 106..135 23/28 (82%)
ANK repeat 139..170 CDD:293786 24/30 (80%)
ANK 5 139..168 22/28 (79%)
ANK repeat 172..203 CDD:293786 23/30 (77%)
ANK 6 172..201 22/28 (79%)
ANK repeat 205..236 CDD:293786 20/30 (67%)
ANK 7 205..234 19/28 (68%)
PHA03095 212..>493 CDD:222980 201/280 (72%)
ANK 8 238..267 24/28 (86%)
ANK repeat 238..266 CDD:293786 23/27 (85%)
ANK repeat 271..302 CDD:293786 28/30 (93%)
ANK 9 271..301 27/29 (93%)
ANK repeat 305..336 CDD:293786 24/30 (80%)
ANK 10 305..334 22/28 (79%)
ANK repeat 338..369 CDD:293786 26/30 (87%)
ANK 11 338..367 25/28 (89%)
ANK repeat 375..420 CDD:293786 22/44 (50%)
ANK repeat 422..453 CDD:293786 24/30 (80%)
ANK 13 422..451 23/28 (82%)
ANK repeat 455..486 CDD:293786 19/30 (63%)
ANK 14 455..484 18/28 (64%)
ANK repeat 488..547 CDD:293786 20/58 (34%)
ANK 15 488..516 9/27 (33%)
ANKYR 510..767 CDD:440430 153/299 (51%)
ANK repeat 549..580 CDD:293786 19/40 (48%)
ANK 16 549..579 19/39 (49%)
ANK repeat 582..615 CDD:293786 24/32 (75%)
ANK 17 584..613 23/28 (82%)
ANK 18 617..646 23/28 (82%)
ANK repeat 618..648 CDD:293786 24/29 (83%)
ANK repeat 651..685 CDD:293786 20/66 (30%)
ANK 19 651..680 17/61 (28%)
ANKYR 668..997 CDD:440430 210/329 (64%)
ANK repeat 687..718 CDD:293786 18/30 (60%)
ANK 20 687..716 17/28 (61%)
ANK repeat 720..751 CDD:293786 17/30 (57%)
ANK 21 720..749 16/28 (57%)
ANK 22 753..782 18/28 (64%)
ANK repeat 789..854 CDD:293786 36/64 (56%)
ANK 23 789..818 19/28 (68%)
ANK 24 821..850 13/28 (46%)
ANK 25 856..885 23/28 (82%)
ANK repeat 857..887 CDD:293786 24/29 (83%)
ANK repeat 889..921 CDD:293786 22/31 (71%)
ANK 26 889..919 21/29 (72%)
ANK repeat 923..954 CDD:293786 20/30 (67%)
ANK 27 923..952 19/28 (68%)
ANK repeat 959..990 CDD:293786 26/30 (87%)
ANK 28 959..988 24/28 (86%)
ankrd28XP_031760399.1 PTZ00322 10..>124 CDD:140343 70/86 (81%)
ANK repeat 38..65 CDD:293786 19/26 (73%)
ANK repeat 67..98 CDD:293786 28/30 (93%)
ANKYR 81..370 CDD:440430 236/288 (82%)
ANK repeat 103..131 CDD:293786 24/27 (89%)
ANK repeat 133..164 CDD:293786 25/30 (83%)
ANK repeat 167..197 CDD:293786 24/29 (83%)
ANK repeat 199..230 CDD:293786 23/30 (77%)
ANK repeat 232..263 CDD:293786 20/30 (67%)
ANKYR 249..530 CDD:440430 214/325 (66%)
ANK repeat 265..296 CDD:293786 26/30 (87%)
ANK repeat 298..329 CDD:293786 28/30 (93%)
ANK repeat 332..363 CDD:293786 24/30 (80%)
ANK repeat 365..395 CDD:293786 25/29 (86%)
ANK repeat 402..429 CDD:293786 22/44 (50%)
PHA03100 416..>651 CDD:476869 158/279 (57%)
ANK repeat 431..462 CDD:293786 24/30 (80%)
ANK repeat 464..495 CDD:293786 19/30 (63%)
ANK repeat 497..529 CDD:293786 20/58 (34%)
ANK repeat 531..561 CDD:293786 17/29 (59%)
ANK repeat 563..607 CDD:293786 26/43 (60%)
ANK repeat 609..640 CDD:293786 24/30 (80%)
ANKYR 693..1023 CDD:440430 210/329 (64%)
ANK repeat 712..743 CDD:293786 18/30 (60%)
ANK repeat 745..776 CDD:293786 17/30 (57%)
ANK repeat 882..913 CDD:293786 25/30 (83%)
ANK repeat 915..947 CDD:293786 22/31 (71%)
ANK repeat 949..1016 CDD:293786 49/66 (74%)

Return to query results.
Submit another query.